3245-41-8Relevant academic research and scientific papers
Pyridine as N-[2-(3,4-) - well as] preparation method and application thereof (by machine translation)
-
Paragraph 0023-0025, (2020/01/12)
The invention belongs to the technical field of, peasants, and relates to a N - [2 - (3,4 - novel plant growth regulator (] Dichlorphenoxy-Benzyloxyethyl) pyridine) compound as well as a preparation method and application. of the compound as: shown in the
N-2-(3,4- dichlorophenoxy)-ethyl triethyltriethylhalide amine as well as preparation method and application thereof (by machine translation)
-
Paragraph 0020; 0021; 0022, (2020/02/14)
The invention belongs to the technical field, of peasants, and relates to a 2 - (3,4 - novel plant growth regulator (PA)-phenoxyethyl triethyltriethylhalide amine) compound as well as a preparation method and application thereof, and the compound is shown
MODULATORS OF THE INTEGRATED STRESS PATHWAY
-
Page/Page column 267-269, (2019/05/22)
Provided herein are compounds, compositions, and methods useful for the modulation of elF2B, for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
MODULATORS OF THE INTEGRATED STRESS PATHWAY
-
Page/Page column 239-240, (2017/12/14)
Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
Synthetic process of DCPTA
-
Paragraph 0030; 0031; 0032; 0033; 0034, (2017/02/17)
The invention discloses a synthetic process of DCPTA [2-(3,4-dichlorophenoxy)trithylamine] and belongs to the technical field of fine chemicals. The process comprises the following steps: A, 3,4-Dichlorophenol and alkali metal hydroxide are dissolved into
DOPAMINE D2 RECEPTOR LIGANDS
-
Page/Page column 126, (2016/07/05)
The present invention relates to novel dopamine D2 receptor ligands. The invention further relates to functionally-biased dopamine D2 receptor ligands and the use of these compounds for treating or preventing central nervous system and systemic disorders associated with dysregulation of dopaminergic activity. The present invention relates to novel compounds that modulate dopamine D2 receptors. In particular, compounds of the present invention show functional selectivity at the dopamine D2 receptors and exhibit selectivity downstream of the D2 receptors, on the 0- arrestin pathway and/or on the cAMP pathway.
